ACTELION PHARMACEUTICALS LTD v. ZYDUS PHARMACEUTICALS (USA) INC. et al > Summary
Court Case Number 3:18-cv-01397
Filing Date Jan 31, 2018
Termination Date Sep 22, 2020
Court New Jersey District Court
Status Judgment - Judgment on Consent
JudgesFreda L. Wolfson, Lois H. Goodman
Plaintiff
Plaintiff Attorneys
15Actelion Pharmaceuticals
Attorney Name: William C. Baton
Saul Ewing LLP
Actelion Pharmaceuticals
Attorney Name: Rebecca Hilgar
Paul Hastings
Actelion Pharmaceuticals
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Actelion Pharmaceuticals
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Actelion Pharmaceuticals
Attorney Name: Bruce M. Wexler
Paul Hastings
Actelion Pharmaceuticals
Attorney Name: Preston K. Ratliff II
Paul Hastings
Actelion Pharmaceuticals
Attorney Name: Simon F Kung
Paul Hastings
Actelion Pharmaceuticals
Attorney Name: Yousef M. Mian
Paul Hastings
Actelion Pharmaceuticals
Attorney Name: Alison Mulry
Paul Hastings
Actelion Pharmaceuticals
Attorney Name: Maria C. Nunez
Paul Hastings
Actelion Pharmaceuticals
Attorney Name: Elizabeth T. Bernard
Paul Hastings
Actelion Pharmaceuticals
Attorney Name: Mark Russell Sperling
Paul Hastings
Actelion Pharmaceuticals
Attorney Name: Ashley N. Mays-Williams
Paul Hastings
Attorney Name: Rebecca Hilgar
Attorney Name: Mark Russell Sperling
Defendant Attorneys
11Zydus Pharmaceuticals
Attorney Name: Eric I. Abraham
Hill Wallack LLP
Zydus Pharmaceuticals
Attorney Name: Paul B. Sudentas
Locke Lord
Zydus Pharmaceuticals
Attorney Name: Andrea L. Wayda
Locke Lord
Zydus Pharmaceuticals
Attorney Name: Michael J. Gaertner
Locke Lord
Zydus Pharmaceuticals
Attorney Name: James T. Peterka
Locke Lord
Zydus Pharmaceuticals
Attorney Name: Wasim K. Bleibel
Locke Lord
Zydus Pharmaceuticals
Attorney Name: Christopher J. Cassella
Locke Lord
Attorney Name: Yevgenia Shtilman Kleiner
Attorney Name: Paul B. Sudentas
Attorney Name: Christina Saveriano
Attorney Name: Andrea L. Wayda
Cause
15:1126 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07094781 | Sulfamides and their use as endothelin receptor antagonists | Aug 22, 2006 |
